Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

April 8, 2027

Study Completion Date

September 30, 2027

Conditions
Unresectable/Metastatic Gastric Cancer
Interventions
DRUG

Sintilimab+irinotecan+leucovorin folinate+fluorouracil

sintilimab 3mg/kg for patients with body weight\<60kg or 200mg for patients with body weight ≥ 60kg, plus irinotecan 180mg/m2 intravenous infusion, leucovorin folinate 400mg/m2 intravenous infusion and fluorouracil 400mg/m2 intravenous injection followed by 2400mg/m2 intravenous infusion for 48 hours, repeated every two weeks.

Trial Locations (1)

510000

RECRUITING

Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER